Cubist Systematic Strategies, LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$17,000
-32.0%
9,3460.0%0.00%
Q1 2022$25,000
-37.5%
9,3460.0%0.00%
Q4 2021$40,000
-16.7%
9,3460.0%0.00%
-100.0%
Q3 2021$48,000
-20.0%
9,346
-1.7%
0.00%0.0%
Q2 2021$60,000
-17.8%
9,5060.0%0.00%0.0%
Q1 2021$73,000
-70.6%
9,506
-74.9%
0.00%
-66.7%
Q4 2020$248,000
+55.0%
37,847
+57.4%
0.00%
+50.0%
Q3 2020$160,000
+207.7%
24,044
+282.6%
0.00%
+100.0%
Q2 2020$52,000
-50.5%
6,285
-54.0%
0.00%
-66.7%
Q1 2020$105,000
-7.1%
13,656
+0.1%
0.00%
+50.0%
Q4 2019$113,000
-78.5%
13,649
-70.8%
0.00%
-80.0%
Q2 2019$525,000
+222.1%
46,779
+208.2%
0.01%
+100.0%
Q1 2019$163,000
-72.3%
15,178
-61.0%
0.01%
-82.1%
Q4 2018$588,000
+27.5%
38,946
+56.3%
0.03%
+12.0%
Q3 2018$461,000
+142.6%
24,923
+199.4%
0.02%
+150.0%
Q2 2018$190,000
-68.3%
8,325
-60.5%
0.01%
-71.4%
Q1 2018$600,000
+6.4%
21,079
-21.1%
0.04%
+16.7%
Q4 2017$564,000
+224.1%
26,727
+137.9%
0.03%
+172.7%
Q2 2017$174,00011,2350.01%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders